Revolutionizing
Joshua’s Lab Inc is at the forefront of Biotechnology, pioneering solutions through its RNA based EXIRO platform for Alzheimers disease today and other neurological disorders, cancers and viruses tomorrow. Join us in transforming healthcare.
Discover Our Journey
Joshua’s Lab Inc is dedicated to revolutionizing the treatment of Alzheimers, other neurological disorders, cancers and viruses through its innovative RNA gene editing platform, also known as EXIRO. Our mission is to enhance patient outcomes by targeting the root causes of these conditions with cutting-edge solutions.
We have exclusively licensed a Major patent which will allow our revolutionary new RNA gene editing EXIRO Platform to leapfrog our competition in the Biotech industry.
We have established a set of important and ambitious goals that we aim to achieve in the next three years. These objectives are crucial not only to our team’s success but also to the broader vision of our organization. In order to reach these milestones, we are fortunate to have a small but dedicated and talented and team at our disposal. At the helm of this team is an outstanding scientist who brings a wealth of knowledge, expertise, and innovative ideas to the table. This leader is not only a brilliant mind in the field but also serves as a source of inspiration and encouragement for each and every team member. Together, we are committed to staying focused on our mission, collaborating effectively, and overcoming the challenges that may arise along the way. With our collective efforts and unwavering determination, I am confident that we will make significant strides toward fulfilling our goals and setting a solid foundation for future endeavors.
By collaborating closely with a major leading research University renowned for its expertise and innovation in our field, we are poised to develop a robust and comprehensive network. This partnership will not only enhance our collective skill sets but also accelerate our progress significantly in the development and refinement of our platform. Through shared resources, knowledge exchange, and access to cutting-edge research methodologies, we will create an environment that fosters creativity and problem-solving. As we work side by side with esteemed researchers and industry experts, we will be better equipped to tackle complex challenges and implement innovative solutions that will ultimately elevate our Exiro platform to new heights. The synergy generated by this collaboration will drive us forward, ensuring that we stay at the forefront of technological advancements and remain competitive in an ever-evolving landscape.
Revolutionizing RNA Gene Editing Technologies
Joshua’s Lab Inc is at the forefront of RNA gene editing, creating the EXIRO platform that will one day offer groundbreaking solutions for neurological disorders, cancers and viruses. Our EXIRO platform will leverage patented advancements to provide a unified approach to treatment.
Innovative Approach
Cutting-edge Platform
Targeting Neurological Disorders, like Alzheimers now and other neurological disorders, cancers and viruses tomorrow
At Joshua’s Lab Inc, we are creating the RNA gene editing EXIRO platform to tackle Alzheimers, other complex neurological disorders, cancers and viruses. Our platform will target the genetic root causes, offering personalized treatment options that enhance patient outcomes and improve quality of life.
Meet Our Team
Dr. Leslie Wolfe , P.H.D.
Chief Technology Officer
Dr. Wolfe has worked in the field of biotechnology for over 30 years with a focus on cell and gene therapy drug development. Dr. Wolfe has spent most of her time working for large corporations like Genzyme and Sanofi; however, Dr. Wolfe has also worked for small start up companies and all of these experiences have given her invaluable knowledge on the production and testing of drug candidates. Dr. Wolfe’s expertise allows her to provide guidance in all aspects of process development, analytical assays, regulatory documentations as well as strategies for operations, scaling and capacity modeling for the manufacturing of products in the cell and gene therapy space.
Michael Jansen
President
Michael Jansen has successfully built three startups into multi-million-dollar companies. At Joshua’s Lab, he is responsible for fundraising, providing investment capital, and managing outside investor relationships. His unique background in entrepreneurship and the law has been instrumental in creating Joshua’s Lab with Dr. Wolfe. Mr. Jansen helped to negotiate an intellectual property licensing agreement with a major biotech university. Although he never practiced law, his legal knowledge and business experience have guided Joshua’s Lab to where it is today.
Join Our Team
Email: mjansen@joshuaslab.com
Email: lwolfe@joshuaslab.com
Tel: 954-955-8878
12481 SW 1st St Plantation Fl 33325